Book by None
"Sinopsis" puede pertenecer a otra edición de este libro.
The polymerase chain reaction (PCR) has proved to be a powerful and versatile tool and has opened new avenues in molecular biol ogy. Alternative nucleic acid amplification techniques, such as the ligase chain reaction (LCR), nucleic acid sequence-based amplifica tion (NASBA), and transcription-mediated amplification (TMA), a variation of NASBA, are also now available. These techniques are all designed to amplify specific nucleic acid sequences in an expo nential manner, thus providing a basis for extremely sensitive diag nostic assays. However, despite the widespread and successful ap plication of genomic amplification techniques in biological research, they have not yet reached the point of routine use in clini cal laboratories. Thus, although the R&D investment in nucleic acid diagnostics is in excess of $250 million annually, clinical ap plications remain relatively modest. One of the principal reasons for this delay in clinical application has been the problem of acci dental contamination of negative clinical specimens with minute amounts of amplified products from a previous positive reaction. Carry-over contamination of amplicons can now be prevented by chemical means or the use of a closed reaction system. However, the current instrumentation is essentially modular in nature, com prising machines that perform the three essential steps of nucleic acid amplification technology: sample preparation, the amplifica tion reaction, and detection of products. Consequently, the test pro cedures are more complicated with somewhat lower sample throughput than the enzyme immunoassays currently performed in clinical laboratories.
"Sobre este título" puede pertenecer a otra edición de este libro.
Gastos de envío:
EUR 18,00
De Reino Unido a Estados Unidos de America
Gastos de envío:
GRATIS
A Estados Unidos de America
Librería: booksXpress, Bayonne, NJ, Estados Unidos de America
Soft Cover. Condición: new. Nº de ref. del artículo: 9781461275435
Cantidad disponible: 10 disponibles
Librería: Lucky's Textbooks, Dallas, TX, Estados Unidos de America
Condición: New. Nº de ref. del artículo: ABLIING23Mar2716030028918
Cantidad disponible: Más de 20 disponibles
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
Condición: New. Nº de ref. del artículo: 18676395-n
Cantidad disponible: 5 disponibles
Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Alemania
Taschenbuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The polymerase chain reaction (PCR) has proved to be a powerful and versatile tool and has opened new avenues in molecular biol ogy. Alternative nucleic acid amplification techniques, such as the ligase chain reaction (LCR), nucleic acid sequence-based amplifica tion (NASBA), and transcription-mediated amplification (TMA), a variation of NASBA, are also now available. These techniques are all designed to amplify specific nucleic acid sequences in an expo nential manner, thus providing a basis for extremely sensitive diag nostic assays. However, despite the widespread and successful ap plication of genomic amplification techniques in biological research, they have not yet reached the point of routine use in clini cal laboratories. Thus, although the R&D investment in nucleic acid diagnostics is in excess of $250 million annually, clinical ap plications remain relatively modest. One of the principal reasons for this delay in clinical application has been the problem of acci dental contamination of negative clinical specimens with minute amounts of amplified products from a previous positive reaction. Carry-over contamination of amplicons can now be prevented by chemical means or the use of a closed reaction system. However, the current instrumentation is essentially modular in nature, com prising machines that perform the three essential steps of nucleic acid amplification technology: sample preparation, the amplifica tion reaction, and detection of products. Consequently, the test pro cedures are more complicated with somewhat lower sample throughput than the enzyme immunoassays currently performed in clinical laboratories. 300 pp. Englisch. Nº de ref. del artículo: 9781461275435
Cantidad disponible: 2 disponibles
Librería: Ria Christie Collections, Uxbridge, Reino Unido
Condición: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book. Nº de ref. del artículo: ria9781461275435_lsuk
Cantidad disponible: Más de 20 disponibles
Librería: GreatBookPricesUK, Castle Donington, DERBY, Reino Unido
Condición: New. Nº de ref. del artículo: 18676395-n
Cantidad disponible: 5 disponibles
Librería: moluna, Greven, Alemania
Condición: New. Nº de ref. del artículo: 4190147
Cantidad disponible: Más de 20 disponibles
Librería: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irlanda
Condición: New. 2011. Paperback. . . . . . Nº de ref. del artículo: V9781461275435
Cantidad disponible: 15 disponibles
Librería: AHA-BUCH GmbH, Einbeck, Alemania
Taschenbuch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - The polymerase chain reaction (PCR) has proved to be a powerful and versatile tool and has opened new avenues in molecular biol ogy. Alternative nucleic acid amplification techniques, such as the ligase chain reaction (LCR), nucleic acid sequence-based amplifica tion (NASBA), and transcription-mediated amplification (TMA), a variation of NASBA, are also now available. These techniques are all designed to amplify specific nucleic acid sequences in an expo nential manner, thus providing a basis for extremely sensitive diag nostic assays. However, despite the widespread and successful ap plication of genomic amplification techniques in biological research, they have not yet reached the point of routine use in clini cal laboratories. Thus, although the R&D investment in nucleic acid diagnostics is in excess of $250 million annually, clinical ap plications remain relatively modest. One of the principal reasons for this delay in clinical application has been the problem of acci dental contamination of negative clinical specimens with minute amounts of amplified products from a previous positive reaction. Carry-over contamination of amplicons can now be prevented by chemical means or the use of a closed reaction system. However, the current instrumentation is essentially modular in nature, com prising machines that perform the three essential steps of nucleic acid amplification technology: sample preparation, the amplifica tion reaction, and detection of products. Consequently, the test pro cedures are more complicated with somewhat lower sample throughput than the enzyme immunoassays currently performed in clinical laboratories. Nº de ref. del artículo: 9781461275435
Cantidad disponible: 1 disponibles
Librería: THE SAINT BOOKSTORE, Southport, Reino Unido
Paperback / softback. Condición: New. This item is printed on demand. New copy - Usually dispatched within 5-9 working days. Nº de ref. del artículo: C9781461275435
Cantidad disponible: Más de 20 disponibles